Hepatitis B virus DNA detected in formalin-fixed liver specimens and its relation to serologic markers and histopathologic features in chronic liver disease. 1985

P J Rijntjes, and T J Van Ditzhuijsen, and A M Van Loon, and U J Van Haelst, and F B Bronkhorst, and S H Yap

To examine the relationship of hepatitis B virus (HBV) DNA sequences in the liver with histopathologic features and antigenic markers, the authors determined the hepatocytic status of viral DNA by in situ hybridization in formalin-fixed liver sections using a biotinylated probe in 45 patients with various chronic liver diseases. The results were compared retrospectively with the HBV serologic markers and histopathologic features including the presence of ground-glass cells or Shikata staining positivity. The specificity of this in situ detection of HBV DNA has been proven excellent in a double-blind control study in 18 patients in whom liver HBV DNA was also determined by DNA extraction, gel electrophoresis, and the Southern blotting technique. In 41 patients, the findings of HBV DNA and serologic markers were concordant (17 positive and 24 negative). Twelve of the 20 HBV-DNA-positive patients were HBsAg-positive (6 with chronic hepatitis, 3 with cirrhosis, and 3 with hepatocellular carcinoma). Ground-glass cells or Shikata positivity were found in 10 of these 12 patients. HBV DNA sequences were found in the liver of all patients with chronic liver disease and serologic positivity for HBV infection. In liver with normal histologic features, HBV DNA was not demonstrable, despite the positive anti-HBc and anti-HBs. However, a positive HBV DNA was found in 3 serologically negative patients. In another patient the interpretation of findings was impossible because of severe hemosiderosis. From this study, it is concluded that in situ detection of HBV DNA in formalin-fixed liver sections has a clinical value and is suitable for routine use.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009693 Nucleic Acid Hybridization Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503) Genomic Hybridization,Acid Hybridization, Nucleic,Acid Hybridizations, Nucleic,Genomic Hybridizations,Hybridization, Genomic,Hybridization, Nucleic Acid,Hybridizations, Genomic,Hybridizations, Nucleic Acid,Nucleic Acid Hybridizations
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005189 False Positive Reactions Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) False Positive Reaction,Positive Reaction, False,Positive Reactions, False,Reaction, False Positive,Reactions, False Positive
D005260 Female Females

Related Publications

P J Rijntjes, and T J Van Ditzhuijsen, and A M Van Loon, and U J Van Haelst, and F B Bronkhorst, and S H Yap
February 1994, Atencion primaria,
P J Rijntjes, and T J Van Ditzhuijsen, and A M Van Loon, and U J Van Haelst, and F B Bronkhorst, and S H Yap
November 1979, Mayo Clinic proceedings,
P J Rijntjes, and T J Van Ditzhuijsen, and A M Van Loon, and U J Van Haelst, and F B Bronkhorst, and S H Yap
July 1987, The New England journal of medicine,
P J Rijntjes, and T J Van Ditzhuijsen, and A M Van Loon, and U J Van Haelst, and F B Bronkhorst, and S H Yap
January 1990, Journal of gastroenterology and hepatology,
P J Rijntjes, and T J Van Ditzhuijsen, and A M Van Loon, and U J Van Haelst, and F B Bronkhorst, and S H Yap
February 1992, Journal of pediatric gastroenterology and nutrition,
P J Rijntjes, and T J Van Ditzhuijsen, and A M Van Loon, and U J Van Haelst, and F B Bronkhorst, and S H Yap
April 1985, Medicina clinica,
P J Rijntjes, and T J Van Ditzhuijsen, and A M Van Loon, and U J Van Haelst, and F B Bronkhorst, and S H Yap
March 1999, Journal of hepatology,
P J Rijntjes, and T J Van Ditzhuijsen, and A M Van Loon, and U J Van Haelst, and F B Bronkhorst, and S H Yap
January 1981, Annual review of medicine,
P J Rijntjes, and T J Van Ditzhuijsen, and A M Van Loon, and U J Van Haelst, and F B Bronkhorst, and S H Yap
February 1986, Seminars in liver disease,
P J Rijntjes, and T J Van Ditzhuijsen, and A M Van Loon, and U J Van Haelst, and F B Bronkhorst, and S H Yap
November 1980, The Journal of infectious diseases,
Copied contents to your clipboard!